Distribution of PDE8A in the nervous system of the Sprague-Dawley rat

Journal of Chemical Neuroanatomy

Volumn 42, Issue 3, 2011, Pages 184-191

  Kruse, Lars Schack ^a   Møller, Morten ^a   Kruuse, Christina ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Brain; Immunohistochemistry; Pain; PDE8; Phosphodiesterase; Trigeminal ganglion

Indexed keywords

CYCLIC AMP; PHOSPHODIESTERASE; PROTEIN CYCLIC NUCLEOTIDE PHOSPHODIESTERASE 8A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN STEM; CELLULAR DISTRIBUTION; CEREBELLUM; CHOROID PLEXUS; COGNITION; CYTOPLASM; DURA MATER; ENZYME LOCALIZATION; EPITHELIUM; FOREBRAIN; GRANULAR CELL; HIPPOCAMPUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTOR PERFORMANCE; NERVOUS SYSTEM; NONHUMAN; OLFACTORY BULB; PERIKARYON; PRINCIPAL SENSORY NUCLEUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PURKINJE CELL; RAT; SEPTUM PELLUCIDUM; SIGNAL TRANSDUCTION; SMELLING; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA; THALAMUS RETICULAR NUCLEUS; TRIGEMINUS GANGLION; WESTERN BLOTTING; ZONA INCERTA;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ANIMALS; BRAIN; IMMUNOHISTOCHEMISTRY; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRIGEMINAL GANGLION;

EID: 80053131680     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2011.07.002     Document Type: Article

References (40)

1. Ahmed T., Frey J.U. Expression of the specific type IV phosphodiesterase gene PDE4B3 during different phases of long-term potentiation in single hippocampal slices of rats in vitro. Neuroscience 2003, 117(3):627-638.
2. Baillie G.S., Scott J.D., Houslay M.D. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Lett 2005, 579(15):3264-3270.
3. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995, 75:725-748.
4. Bender A.T., Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006, 58(3):488-520.
5. Boolell M., Allen M.J., Ballard S.A., Gepi Attee S., Muirhead G.J., Naylor A.M., Osterloh I.H., Gingell C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996, 8:47-52.
6. Breer H. Olfactory receptors: molecular basis for recognition and discrimination of odors. Anal Bioanal Chem 2003, 377(3):427-433.
7. Cooper D.M. Compartmentalization of adenylate cyclase and cAMP signalling. Biochem Soc Trans 2005, 33(Pt 6):1319-1322.
8. Dong H., Osmanova V., Epstein P.M., Brocke S. Phosphodiesterase 8 (PDE8) regulates chemotaxis of activated lymphocytes. Biochem Biophys Res Commun 2006, 345(2):713-719.
9. Fisher D.A., Smith J.F., Pillar J.S., St Denis S.H., Cheng J.B. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem Biophys Res Commun 1998, 246(3):570-577.
10. Giorgi M., D'Angelo V., Esposito Z., Nuccetelli V., Sorge R., Martorana A., Stefani A., Bernardi G., Sancesario G. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Eur J Neurosci 2008, 28(5):941-950.
11. Goadsby P.J. Migraine pathophysiology. Headache 2005, 45(Suppl 1):S14-S24.
12. Guy N., Chalus M., Dallel R., Voisin D.L. Both oral and caudal parts of the spinal trigeminal nucleus project to the somatosensory thalamus in the rat. Eur J Neurosci 2005, 21(3):741-754.
13. Hannibal J., Mikkelsen J.D., Clausen H., Holst J.J., Wulff B.S., Fahrenkrug J. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul Pept 1995, 55(2):133-148.
14. Ito M. Mechanisms of motor learning in the cerebellum. Brain Res 2000, 886(1-2):237-245.
15. Kobayashi T., Gamanuma M., Sasaki T., Yamashita Y., Yuasa K., Kotera J., Omori K. Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain. Gene 2003, 319:21-31.
16. Kruse L.S., Moller M., Tibaek M., Gammeltoft S., Olesen J., Kruuse C. PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system. Brain Res 2009, 1281:25-34.
17. Kruse L.S., Sandholdt N.T., Gammeltoft S., Olesen J., Kruuse C. Phosphodiesterase 3 and 5 and cyclic nucleotide-gated ion channel expression in rat trigeminovascular system. Neurosci Lett 2006, 404(1-2):202-207.
18. Kruuse C., Jacobsen T.B., Lassen L.H., Thomsen L.L., Hasselbalch S.G., Dige-Petersen H., Olesen J. Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects. J Cereb Blood Flow Metab 2000, 20(9):1372-1379.
19. Kruuse C., Lassen L.H., Iversen H.K., Oestergaard S., Olesen J. Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 2006, 26(8):925-933.
20. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 2006, 109(3):366-398.
21. Menniti F.S., Chappie T.A., Humphrey J.M., Schmidt C.J. Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia. Curr Opin Investig Drugs 2007, 8(1):54-59.
22. Michelakis E., Tymchak W., Lien D., Webster L., Hashimoto K., Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 2002, 105(20):2398-2403.
23. Miro X., Perez-Torres S., Palacios J.M., Puigdomenech P., Mengod G. Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs. Synapse 2001, 40(3):201-214.
24. Miro X., Perez-Torres S., Puigdomenech P., Palacios J.M., Mengod G. Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization. Synapse 2002, 45(4):259-269.
25. Omori K., Kotera J. Overview of PDEs and their regulation. Circ Res 2007, 100(3):309-327.
26. Perez-Torres S., Cortes R., Tolnay M., Probst A., Palacios J.M., Mengod G. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp Neurol 2003, 182(2):322-334.
27. Reneerkens O.A., Rutten K., Steinbusch H.W., Blokland A., Prickaerts J. Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl) 2009, 202(1-3):419-443.
28. Restrepo D., Miyamoto T., Bryant B.P., Teeter J.H. Odor stimuli trigger influx of calcium into olfactory neurons of the channel catfish. Science 1990, 249(4973):1166-1168.
29. Shimizu-Albergine M., Rybalkin S.D., Rybalkina I.G., Feil R., Wolfsgruber W., Hofmann F., Beavo J.A. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation. J Neurosci 2003, 23(16):6452-6459.
30. Soderling S.H., Bayuga S.J., Beavo J.A. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci USA 1998, 95(15):8991-8996.
31. Strada S.J., Uzunov P., Weiss B. Ontogenic development of a phosphodiesterase activator and the multiple forms of cyclic AMP phosphodiesterase of rat brain. J Neurochem 1974, 23(6):1097-1103.
32. Uzunov P., Weiss B. Separation of multiple molecular forms of cyclic adenosine-3',5'-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis. Biochim Biophys Acta 1972, 284(1):220-226.
33. Van Staveren W.C., Steinbusch H.W., Markerink-Van Ittersum M., Repaske D.R., Goy M.F., Kotera J., Omori K., Beavo J.A., De Vente J. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. J Comp Neurol 2003, 467(4):566-580.
34. Vang A.G., Ben-Sasson S.Z., Dong H., Kream B., DeNinno M.P., Claffey M.M., Housley W., Clark R.B., Epstein P.M., Brocke S. PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER. PLoS ONE 2010, 5(8):e12011.
35. Waeber C., Moskowitz M.A. Migraine as an inflammatory disorder. Neurology 2005, 64(10 Suppl 2):S9-S15.
36. Wang H., Yan Z., Yang S., Cai J., Robinson H., Ke H. Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity. Biochemistry 2008, 47(48):12760-12768.
37. Wang J., Huo F.Q., Li Y.Q., Chen T., Han F., Tang J.S. Thalamic nucleus submedius receives GABAergic projection from thalamic reticular nucleus in the rat. Neuroscience 2005, 134(2):515-523.
38. Wang P., Wu P., Egan R.W., Billah M.M. Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution. Gene 2001, 280(1-2):183-194.
39. Wilson L.S., Elbatarny H.S., Crawley S.W., Bennett B.M., Maurice D.H. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions. Proc Natl Acad Sci USA 2008, 105(36):13650-13655.
40. Yan Z., Wang H., Cai J., Ke H. Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain. Protein Expr Purif 2009, 64(1):82-88.